Evidence map›Paper›PMID 29615725›Full record

ArticleScientific reports2018

Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection.

Milena S Espíndola, Luana S Soares, Leonardo J Galvão-Lima, Fabiana A Zambuzi, Maira C Cacemiro, Verônica S Brauer, Cleni M Marzocchi-Machado, Matheus de Souza Gomes, Laurence R Amaral, Olindo A Martins-Filho and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Immuno-cell metabolic changes in HIV-1 infection.Infectious diseases & immunity · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Role of Monocyte/Macrophages in the Pathogenesis of NeuroHIV.Results and problems in cell differentiation · 2024
    Review
  13. Dominant CD4Cell reports. Medicine · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Trained Immunity and HIV Infection.Frontiers in immunology · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Milena S EspíndolaFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Luana S SoaresFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Leonardo J Galvão-LimaFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Fabiana A ZambuziFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Maira C CacemiroFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Verônica S BrauerFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Cleni M Marzocchi-MachadoFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Matheus de Souza GomesLaboratorio de Bioinformatica e Analises Moleculares - INGEB/FACOM, Universidade Federal de Uberlandia, Patos de Minas, MG, Brazil.
Laurence R AmaralLaboratorio de Bioinformatica e Analises Moleculares - INGEB/FACOM, Universidade Federal de Uberlandia, Patos de Minas, MG, Brazil.ORCID 0000-0003-4681-5451
Olindo A Martins-FilhoLaboratorio de Biomarcadores para Diagnostico e Monitoramento, Centro de Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, MG, Brazil.
Valdes R BollelaFaculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil.
Fabiani G FrantzFaculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil. frantz@usp.br.ORCID 0000-0001-6960-2438
Universidade de São Paulo · BRUniversidade de Ribeirão Preto · BRUniversidade Federal de Viçosa · BRFundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocytes are key cells in the immune dysregulation observed during human immunodeficiency virus (HIV) infection. The events that take place specifically in monocytes may contribute to the systemic immune dysfunction characterized by excessive immune activation in infected individuals, which directly correlates with pathogenesis and progression of the disease. Here, we investigated the immune dysfunction in monocytes from untreated and treated HIV + patients and associated these findings with epigenetic changes. Monocytes from HIV patients showed dysfunctional ability of phagocytosis and killing, and exhibited dysregulated cytokines and reactive oxygen species production after M. tuberculosis challenge in vitro. In addition, we showed that the expression of enzymes responsible for epigenetic changes was altered during HIV infection and was more prominent in patients that had high levels of soluble CD163 (sCD163), a newly identified plasmatic HIV progression biomarker. Among the enzymes, histone acetyltransferase 1 (HAT1) was the best epigenetic biomarker correlated with HIV - sCD163 high patients. In conclusion, we confirmed that HIV impairs effector functions of monocytes and these alterations are associated with epigenetic changes that once identified could be used as targets in therapies aiming the reduction of the systemic activation state found in HIV patients.

Indexed as

Epigenesis, GeneticAdolescentAdultAgedAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenDisease ProgressionEnzyme ActivationFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedMonocytesAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenReceptors, Cell Surface

Identifiers

PMID29615725
PMCPMC5882962
OpenAlexW2800507055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.